ABCB1基因变异与性别影响脑内5-羟色胺转运体占据率
研究纳入79名受试者(31例重性抑郁患者、48名健康志愿者),采用交叉设计 PET/MRI 与安慰剂对照的西酞普兰8 mg输注,评估 ABCB1 六个单核苷酸多态性对脑内 SERT 占据率的影响。结果显示 rs2235015 次要等位基因携带者及男性的 SERT 占据率更低,提示基因与性别可影响西酞普兰的靶点结合。
要点
- rs2235015次要等位基因携带者西酞普兰的SERT占据率低于主要等位基因纯合子。
- 男性SERT占据率低于女性,且结果对血浆浓度、年龄与诊断校正稳健。
- 模型提示相同剂量下占据/未占据SERT比值受基因型、性别、体重与年龄影响。
核心结论
- ABCB1 rs2235015变异与性别影响西酞普兰在脑内对SERT的占据,支持个体化初始剂量探索。
研究设计与样本
- 79名受试者(39名女性,含31例重性抑郁患者与48名健康志愿者)接受两次[11C]DASB PET/MRI扫描。
- 采用安慰剂对照、交叉设计,输注西酞普兰8 mg后即刻测量SERT占据率。
- 检测六个ABCB1单核苷酸多态性对药物靶点结合的影响。
主要发现
- rs2235015次要等位基因携带者(n=26,MAF=0.18)SERT占据率低于主要等位基因纯合子(t73=2.73,pFWE<0.05)。
- 男性SERT占据率低于女性(t73=3.33,pFWE<0.05)。
- 上述效应对西酞普兰血浆浓度、年龄与诊断的校正稳健。
关键数值与推荐
- 模型预测相同剂量下占据/未占据SERT比值在rs2235015次要等位基因携带者中低14.48±5.38%。
- 该比值在女性中高19.10±6.95%,每10 kg体重低4.83±2.70%,每10年年龄低2.68±3.07%。
临床怎么用
- 提示可探索依据ABCB1基因型、性别、体重与年龄调整西酞普兰初始剂量的临床算法。
局限性
- 样本量有限,结果需在更大样本中验证。
- 仅评估单次8 mg西酞普兰输注的即刻占据率,未涉及长期疗效与耐受性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Strategies to personalize psychopharmacological treatment promise to improve efficacy and tolerability. We measured serotonin transporter occupancy immediately after infusion of the widely prescribed P-glycoprotein substrate citalopram and assessed to what extent variants of the ABCB1 gene affect drug target engagement in the brain in vivo. A total of 79 participants (39 female) including 31 patients with major depression and 48 healthy volunteers underwent two PET/MRI scans with the tracer [11C]DASB and placebo-controlled infusion of citalopram (8 mg) in a cross-over design. We tested the effect of six ABCB1 single nucleotide polymorphisms and found lower SERT occupancy in ABCB1 rs2235015 minor allele carriers (n = 26, MAF = 0.18) compared to major allele homozygotes (t73 = 2.73, pFWE < 0.05) as well as in men compared to women (t73 = 3.33, pFWE < 0.05). These effects were robust to correction for citalopram plasma concentration, age and diagnosis. From occupancy we derived the ratio of occupied to unoccupied SERT, because in theory this measure is equal to the product of drug affinity and concentration at target sites. A model combining genotype with basic clinical variables, predicted that, at the same dosage, occupied to unoccupied SERT ratio was -14.48 ± 5.38% lower in rs2235015 minor allele carriers, +19.10 ± 6.95% higher in women, -4.83 ± 2.70% lower per 10 kg bodyweight, and -2.68 ± 3.07% lower per 10 years of age. Our results support the exploration of clinical algorithms with adjustment of initial citalopram dosing and highlight the potential of imaging-genetics for precision pharmacotherapy in psychiatry.
引用
- Silberbauer LR, Rischka L, Vraka C, et al. ABCB1 variants and sex affect serotonin transporter occupancy in the brain. Mol Psychiatry. 2022. PMID: 36071112. doi:10.1038/s41380-022-01733-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。